-
lzI can tell you that 10 years from a technical point of view **will be**a downward process, if there is not a xx flu, Rhine Biotech will not be able to reach 40. 10 yuan is possible, its performance does not support him so **, the long-term must look at the value of the enterprise. The technocracy can't see so far, knowing how to go tomorrow is much more valuable than knowing how valuable it is in the next 1 year, and the stock is technically about to appear **, more than 10 points.
-
1. The current stock price is more than 29 yuan, and it is unimaginable to fall to 10 yuan.
Therefore, your lowest point is too extreme, first of all, it can be ruled out, and it is impossible to reach the position of 10 yuan this year.
2. The highest point of 40 yuan, which is a rather controversial target price, from the point of view of technical analysis, that is, from the monthly ** chart, the probability is very small, about 10% probability.
A big black candle in January, from the perspective of the monthly chart, is a broken long black candle.
Therefore, the highest point of 40 yuan , from the perspective of probability, the probability is not high.
3. All in all, the landlord's two prices, I think the possibility is very small.
Finally, I give you an approximate fluctuation range for the stock in the first half of the year.
Rhine Bio--》26 yuan--- 36 yuan.
**Youdao 45617
-
The main force has run, 40 yuan will definitely not arrive, it is difficult for an institution to take over at this price, the low point of 10 yuan is also a little too low, but it is a fact that there is a lot of space below.
-
The landlord took the last baton.
-
Comprehensive investment advice: The comprehensive score of Laine Biotech (002166) indicates that the investment value of the stock is extremely poor ( ).
12-Step Value Appraisal Investment Advice: Combining the 12-step evaluation of the stock, the stock has a poor investment value ( It is recommended that you take an avoidant attitude towards the stock and wait for better investment opportunities.
Industry Rating Investment Advice: Rhine Biotech (002166) belongs to the biotechnology industry, and the current investment value of this industry is good (the overall ranking of this industry is 4th.
Growth Quality Rating Investment Advice: Rhine Biotech (002166) has extremely poor growth ability ( ) The stock ranks 1436th in terms of growth ability and 6th in its industry growth ability.
-
1. The performance of Rhine Biotech has been very poor, and the main force of the stock often speculates with the help of the opportunity of the launch of national policies.
2. Since the stock has been held, and the market is currently in a bull market, it is advisable to hold it for the time being. According to the previous main operation of this method, after the adjustment, the main force will still have another wave of ** noise, please be patient, then you can take profits at the high.
In the subjunctive mood, the flip structure of the front of the had. >>>More
It's a bit complicated indeed.
1. After the death of Yuan Rongfang and his wife, the three houses were jointly inherited by Liu Gonglin, Liu Gonghua, and Liu Gongying. >>>More
Hello. After reading your problem, I feel as if you have no one in the world who loves you, and I am very disappointed. Yes, pay her feelings, pay time, pay the economy. >>>More
wo according to the time you give is the lunar calendar:
Your destiny is: >>>More
Both men and women will never forget the person they like for the first time! But that doesn't mean we'll be together forever! I think you're just a little nostalgic for your first love that you didn't start! >>>More